Advertisement

International Journal of Hematology

, Volume 88, Issue 3, pp 294–298 | Cite as

Spinal cord compression in an adolescent with relapsed B-precursor acute lymphoblastic leukemia and mental neuropathy

  • Elpis Mantadakis
  • Aspasia Katragkou
  • Eufrosini Papadaki
  • Stefanos Papadhimitriou
  • George Paterakis
  • Eftichia Stiakaki
  • Maria KalmantiEmail author
Case Report

Abstract

The authors report a case of intraspinal mass associated with recurrence of B-precursor acute lymphoblastic leukemia in an adolescent male who presented with numb chin syndrome at initial diagnosis of the leukemia. The patient developed sensory changes, later on motor weakness, and eventually paraplegia. An emergent MRI scan showed an intraspinal mass at the level of T9 vertebra. Biopsy obtained during laminectomy revealed a mass composed of lymphoblasts immunophenotypically identical to the patient’s known leukemia. Surgical decompression and dexamethasone were ineffective in restoration of the neurological deficits. Intraspinal extramedullary relapses should be considered in the differential diagnosis of leukemic patients with neurological symptoms.

Keywords

Acute lymphoblastic leukemia Spinal cord compression Numb chin syndrome 

References

  1. 1.
    Hwang WL, Gau JP, Hu HT, Young JH. Isolated extramedullary relapse of acute lymphoblastic leukemia presenting as an intraspinal mass. Acta Haematol. 1994;91:46–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Kataoka A, Shimizu K, Matsumoto T, Shintaku N, Okuno T, Takahashi Y, et al. Epidural spinal cord compression as an initial symptom in childhood acute lymphoblastic leukemia: rapid decompression by local irradiation and systemic chemotherapy. Pediatr Hematol Oncol. 1995;12:179–84. doi: 10.3109/08880019509029552.CrossRefPubMedGoogle Scholar
  3. 3.
    Buyukavci M, Karacan M, Olgun H, Tan H. Significance of bone marrow examination in the diagnostic process of paraspinal mass in children: a case report. J Pediatr Hematol Oncol. 2003;25:822–3. doi: 10.1097/00043426-200310000-00018.CrossRefPubMedGoogle Scholar
  4. 4.
    Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9:1783–6.PubMedGoogle Scholar
  5. 5.
    Schrappe M, Rizzari C, Mann G, Möricke A, Grazia Valsecchi M, et al. Prognostic impact of minimal residual disease (MRD) in children is different in B or T lineage acute lymphoblastic leukemia: results of trial AIEOP-BFM ALL 2000. Blood. 2007;110:1425a.Google Scholar
  6. 6.
    Kantarjian HM, O’Brien S, Smith TL, Cortes J, Giles FJ, Beran M, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000;18:547–61.CrossRefPubMedGoogle Scholar
  7. 7.
    Jeha S, Gandhi V, Chan KW, McDonald L, Ramirez I, Madden R, et al. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood. 2004;103:784–9. doi: 10.1182/blood-2003-06-2122.CrossRefPubMedGoogle Scholar
  8. 8.
    Bomgaars L, et al. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol. 2004;22:916–21. doi: 10.1200/JCO.2004.01.046.CrossRefGoogle Scholar
  9. 9.
    Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V, et al. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr. 1987;199:151–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Peters C, Schrauder A, Schrappe M, von Stackelberg A, Stary J, Yaniv I, et al. BFM Study Group, the IBFM-Study Group and the Paediatric Disease Working Party of the EBMT. Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts. Bone Marrow Transplant. 2005;35:S9–11. doi: 10.1038/sj.bmt.1704835.CrossRefPubMedGoogle Scholar
  11. 11.
    Drexler HG. Review of alterations of the cyclin dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 1998;12:845–59. doi: 10.1038/sj.leu.2401043.CrossRefPubMedGoogle Scholar
  12. 12.
    Heyman M, Rasool O, Borgonovo Brandter L, Liu Y, Grandér D, et al. Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia. J Clin Oncol. 1996;14:1512–20.CrossRefPubMedGoogle Scholar
  13. 13.
    Kees UR, Burton PR, Lü C, Baker DL. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavourable clinical outcome. Blood. 1997;89:4161–6.PubMedGoogle Scholar
  14. 14.
    Carter TL, Watt PM, Kumar R, Burton PR, Reaman GH, Sather HN, et al. Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. Blood. 2001;97:572–4. doi: 10.1182/blood.V97.2.572.CrossRefPubMedGoogle Scholar
  15. 15.
    Calero Moreno TM, Gustafsson G, Garwicz S, Grandér D, Jonmundsson GK, Frost BM, et al. Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92. Leukemia. 2002;16:2037–45. doi: 10.1038/sj.leu.2402697.CrossRefPubMedGoogle Scholar
  16. 16.
    Rubnitz JE, Behm FG, Pui CH, Evans WE, Relling MV, Raimondi SC, et al. Genetic studies of childhood acute lymphoblastic leukaemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia. 1997;11:1201–6. doi: 10.1038/sj.leu.2400779.CrossRefPubMedGoogle Scholar
  17. 17.
    Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JW, et al. Analysis of a family of cyclin-dependent kinase inhibitors-p15/mts2/ink4b, p16/mts1/ink4a, and p18 genes in acute lymphoblastic leukemia of childhood. Blood. 1995;86:755–60.PubMedGoogle Scholar
  18. 18.
    Benesch M, Urban C. Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments. Expert Opin Pharmacother. 2008;9:301–9. doi: 10.1517/14656566.9.2.301.CrossRefPubMedGoogle Scholar
  19. 19.
    Lee JH, Choi SJ, Lee JH, Seol M, Lee YS, Ryu SG, et al. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia. Haematologica. 2005;90:1380–8.PubMedGoogle Scholar
  20. 20.
    Sweet JM. The numb chin syndrome: a critical sign for primary care physicians. Arch Intern Med. 2004;164:1347–8. doi: 10.1001/archinte.164.12.1347.CrossRefPubMedGoogle Scholar
  21. 21.
    Kuklok KB, Burton RG, Wilhelm ML. Numb chin syndrome leading to a diagnosis of acute lymphoblastic leukemia: report of a case. J Oral Maxillofac Surg. 1997;55:1483–5. doi: 10.1016/S0278-2391(97)90656-X.CrossRefPubMedGoogle Scholar
  22. 22.
    Massey EW, Moore J, Schold SC Jr. Mental neuropathy from systemic cancer. Neurology. 1981;31:1277–81.CrossRefPubMedGoogle Scholar
  23. 23.
    Fenaux P, Lai JL, Miaux O, Zandecki M, Jouet JP, Bauters F. Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases. Br J Haematol. 1989;71:371–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Kuroda Y, Fujiyama F, Ohyama T, Watanabe T, Endo C, Neshige R, et al. Numb chin syndrome secondary to Burkitt’s cell acute leukemia. Neurology. 1991;41:453–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Hiraki A, Nakamura S, Abe K, Takenoshita Y, Horinouchi Y, Shinohara M, et al. Numb chin syndrome as an initial symptom of acute lymphocytic leukemia: report of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:555–61. doi: 10.1016/S1079-2104(97)90120-7.CrossRefPubMedGoogle Scholar
  26. 26.
    Wong EC, Angiolillo AL. Oncologic emergencies. In: Slonim AD, Pollack MM, editors. Pediatric critical care medicine. Philadelphia: Lipincott Williams & Wilkins; 2006. p. 592–3.Google Scholar
  27. 27.
    Loblaw DA, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative’s Neuro-Oncology Disease Site Group. J Clin Oncol. 2005;23:2028–37. doi: 10.1200/JCO.2005.00.067.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2008

Authors and Affiliations

  • Elpis Mantadakis
    • 1
  • Aspasia Katragkou
    • 1
  • Eufrosini Papadaki
    • 2
  • Stefanos Papadhimitriou
    • 3
  • George Paterakis
    • 4
  • Eftichia Stiakaki
    • 1
  • Maria Kalmanti
    • 1
    Email author
  1. 1.Department of Pediatric Hematology/OncologyUniversity Hospital of HeraklionHeraklion, CreteGreece
  2. 2.Department of RadiologyUniversity Hospital of HeraklionHeraklion, CreteGreece
  3. 3.Department of HematologyGeneral District Hospital of Athens “G. Gennimatas”AthensGreece
  4. 4.Department of ImmunologyGeneral District Hospital of Athens “G. Gennimatas”AthensGreece

Personalised recommendations